- Home
- INSW vs TWST Comparison
INSW vs TWST Comparison
Compare INSW & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSW
- TWST
- Stock Information
- Founded
- INSW 1999
- TWST 2013
- Country
- INSW United States
- TWST United States
- Employees
- INSW N/A
- TWST N/A
- Industry
- INSW Semiconductors
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INSW Technology
- TWST Health Care
- Exchange
- INSW Nasdaq
- TWST Nasdaq
- Market Cap
- INSW 1.7B
- TWST 1.8B
- IPO Year
- INSW N/A
- TWST 2018
- Fundamental
- Price
- INSW $37.06
- TWST $29.30
- Analyst Decision
- INSW Buy
- TWST Buy
- Analyst Count
- INSW 2
- TWST 10
- Target Price
- INSW $52.00
- TWST $49.10
- AVG Volume (30 Days)
- INSW 667.0K
- TWST 1.3M
- Earning Date
- INSW 05-08-2025
- TWST 05-05-2025
- Dividend Yield
- INSW 10.80%
- TWST N/A
- EPS Growth
- INSW N/A
- TWST N/A
- EPS
- INSW 6.47
- TWST N/A
- Revenue
- INSW $860,606,000.00
- TWST $347,680,000.00
- Revenue This Year
- INSW N/A
- TWST $22.60
- Revenue Next Year
- INSW $2.64
- TWST $17.65
- P/E Ratio
- INSW $5.73
- TWST N/A
- Revenue Growth
- INSW N/A
- TWST 25.30
- 52 Week Low
- INSW $27.20
- TWST $27.12
- 52 Week High
- INSW $65.32
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- INSW 53.31
- TWST 39.60
- Support Level
- INSW $36.05
- TWST $27.77
- Resistance Level
- INSW $38.20
- TWST $29.52
- Average True Range (ATR)
- INSW 1.04
- TWST 1.69
- MACD
- INSW -0.28
- TWST 0.06
- Stochastic Oscillator
- INSW 31.09
- TWST 34.06
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.